ms and glp 1 A Phase 2 trial just began testing whether a GLP-1 drug can slow brain shrinkage From metabolism to mind: The

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study

Taking glutathione supplements can improve insulin sensitivity and improve liver health

243 The risk of dementia increases with the number of TBIs sustained

Finally, it was recently suggested that IGF-I has significant characteristics to be a good marker for the insulin resistance syndrome and risk of cardiovascular disease, since logistic regression analysis showed that each unit increase in log-transformed IGF-I concentrations was associated with a 90.5% reduction in the risk of metabolic syndrome[274]